A clinical study to know efficacy of formulations, Saptachakra churna and Amalaki churna in Madhumeha management w.s.r Type-2 DM

A Randomised Controlled Clinical Study to Evaluate Efficacy of Saptachakra Churna (Salacia Reticulata) in Madhumeha w.s.r Type-2 DM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043661

Enrollment

Registered

2022-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with FBS range Between 126 - 250 mg/dL and PPBS range between 200 - 350 mg/dL Type-2 Diabetes Mellitus will be selected for the study.

Exclusion criteria

Exclusion criteria: 1. Patients with High blood glucose levels FBS > 250mg/dL and PPBS > 350 mg/dL 2. Patients with complications like DKA, HHS, Diabetic Gangrene and Carbuncles 3. Gestational Diabetes, Patients on Insulin Type 2 Diabetes Mellitus. 4. Diabetes with other Endocrine Disorders are excluded from the study 5. Patients suffering from other Systemic Diseases which may interfere with study will be excluded.

Design outcomes

Primary

Measure	Time frame
Effect of the treatment will be done based on detailed case proforma with objective parameters FBS and PPBSTimepoint: 30 days	—

Secondary

Measure	Time frame
Effect of the treatment will be done based on detailed case proforma with subjective parameters such Prabhuta avila mutra, Ati Kshudha, Ati Trusha, Ati SvedaTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Javeed Chougala

Alvas Ayurveda Medical College and Hospital

drsurpai@gmail.com8921385332

Outcome results